drugset / Trial / NCT04222790
A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity
RandomizedParallel-groupDouble-blindTreatment
Summary
Taxane-induced peripheral neuropathy (TIPN) caused by paclitaxel is a dose-limiting toxicity. The main symptoms of discomfort are numbness, tingling, and burning sensations in the glove-sock-like distribution of the limbs. At present, there are few effective methods for clinical treatment of TIPN, and there is no widely agreed consensus on effective treatment in the world. Therefore, it is of great clinical significance and practical value to carry out clinical research to explore drugs to relieve TIPN.
Timeline
- Start
- 2020-08-28
- Primary completion
- 2022-04-21
- Completion
- 2022-04-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | monosialic gangliosides | Unknown | 80 mg | — |